TY - JOUR
T1 - Radiomics in neuro-oncology
T2 - Basics, workflow, and applications
AU - Lohmann, Philipp
AU - Galldiks, Norbert
AU - Kocher, Martin
AU - Heinzel, Alexander
AU - Filss, Christian P.
AU - Stegmayr, Carina
AU - Mottaghy, Felix M.
AU - Fink, Gereon R.
AU - Shah, N. Jon
AU - Langen, Karl-Josef
N1 - Funding Information:
This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [Project number 428090865 ] (P.L. and N.G.).
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/4
Y1 - 2021/4
N2 - Over the last years, the amount, variety, and complexity of neuroimaging data acquired in patients with brain tumors for routine clinical purposes and the resulting number of imaging parameters have substantially increased. Consequently, a timely and cost-effective evaluation of imaging data is hardly feasible without the support of methods from the field of artificial intelligence (AI). AI can facilitate and shorten various timeconsuming steps in the image processing workflow, e.g., tumor segmentation, thereby optimizing productivity. Besides, the automated and computer-based analysis of imaging data may help to increase data comparability as it is independent of the experience level of the evaluating clinician. Importantly, AI offers the potential to extract new features from the routinely acquired neuroimages of brain tumor patients. In combination with patient data such as survival, molecular markers, or genomics, mathematical models can be generated that allow, for example, the prediction of treatment response or prognosis, as well as the noninvasive assessment of molecular markers. The subdiscipline of AI dealing with the computation, identification, and extraction of image features, as well as the generation of prognostic or predictive mathematical models, is termed radiomics. This review article summarizes the basics, the current workflow, and methods used in radiomics with a focus on feature-based radiomics in neuro-oncology and provides selected examples of its clinical application.
AB - Over the last years, the amount, variety, and complexity of neuroimaging data acquired in patients with brain tumors for routine clinical purposes and the resulting number of imaging parameters have substantially increased. Consequently, a timely and cost-effective evaluation of imaging data is hardly feasible without the support of methods from the field of artificial intelligence (AI). AI can facilitate and shorten various timeconsuming steps in the image processing workflow, e.g., tumor segmentation, thereby optimizing productivity. Besides, the automated and computer-based analysis of imaging data may help to increase data comparability as it is independent of the experience level of the evaluating clinician. Importantly, AI offers the potential to extract new features from the routinely acquired neuroimages of brain tumor patients. In combination with patient data such as survival, molecular markers, or genomics, mathematical models can be generated that allow, for example, the prediction of treatment response or prognosis, as well as the noninvasive assessment of molecular markers. The subdiscipline of AI dealing with the computation, identification, and extraction of image features, as well as the generation of prognostic or predictive mathematical models, is termed radiomics. This review article summarizes the basics, the current workflow, and methods used in radiomics with a focus on feature-based radiomics in neuro-oncology and provides selected examples of its clinical application.
KW - Artificial Intelligence
KW - Machine learning
KW - Deep learning
KW - Glioma
KW - Brain metastases
KW - Multiparametric PET
KW - MRI
U2 - 10.1016/j.ymeth.2020.06.003
DO - 10.1016/j.ymeth.2020.06.003
M3 - Article
C2 - 32522530
SN - 1046-2023
VL - 188
SP - 112
EP - 121
JO - Methods
JF - Methods
ER -